Exact Sciences Corp
Exact Sciences Merged with Abbott, Delisted from Nasdaq
Summary
Exact Sciences Corporation has merged with Abbott Laboratories, resulting in Exact Sciences becoming a wholly-owned subsidiary of Abbott. The merger, which closed on March 23, 2026, involved the conversion of Exact Sciences' common stock into cash and the cancellation of various stock-related awards. Additionally, Exact Sciences' common stock was delisted from the Nasdaq Stock Market. The transaction was valued at approximately $21 billion, funded by a combination of cash on hand and debt financing.
Profitelligence Alerts
Get alerts for EXAS
Be first to know when Exact Sciences Corp files with the SEC.
Filing Categories
Advertisement
About Exact Sciences Corp
Exact Sciences Corp is a prominent biomedical and biotechnology company dedicated to the development, manufacturing, and marketing of proprietary diagnostic tests. Headquartered in Madison, Wisconsin, the company is renowned for its innovative work in the early detection and prevention of colorectal cancer, primarily through its flagship product, Cologuard. This non-invasive stool-based DNA screening test is a breakthrough in cancer diagnostics, allowing for easier and earlier detection of cancerous and pre-cancerous conditions without the need for traditional invasive procedures. Exact Sciences plays a vital role in the health care and life sciences sectors, significantly impacting patient care by providing more accessible screening options. Their commitment to research and development is evident through ongoing efforts to expand their diagnostic offerings, which include tests for other critical health conditions. In the financial markets, Exact Sciences is a key player in the medical diagnostics and biotechnology industries, with substantial influence on the development of new cancer screening methodologies. The company's innovative approach not only aims to improve patient outcomes but also helps reduce costs in healthcare by enabling timely interventions.
Official SEC Documents
Advertisement